digitoxigenin monodigitoxoside has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbosa, LA; Braga, FC; Cortes, VF; Kreis, W; Munkert, J; Pádua, RM; Persich, L; Ramos, ACP; Rocha, SC; Schneider, NFZ; Silva, IT; Simões, CMO; Taranto, AG | 1 |
Braga, FC; Geller, FC; Kreis, W; Marostica, LL; Pádua, RM; Persich, L; Schneider, NF; Simões, CM | 1 |
2 other study(ies) available for digitoxigenin monodigitoxoside and Lung Neoplasms
Article | Year |
---|---|
Cytotoxic and cytostatic effects of digitoxigenin monodigitoxoside (DGX) in human lung cancer cells and its link to Na,K-ATPase.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Survival; Digitoxigenin; Humans; Lung Neoplasms; Molecular Docking Simulation; Sodium-Potassium-Exchanging ATPase; Swine; Time Factors | 2018 |
Inhibition of cell proliferation, invasion and migration by the cardenolides digitoxigenin monodigitoxoside and convallatoxin in human lung cancer cell line.
Topics: A549 Cells; Cardenolides; Cardiac Glycosides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Digitoxigenin; Humans; Lung Neoplasms; Neoplasm Metastasis; Strophanthins | 2016 |